Rite Aid Is Running Out of Options – U.S. News & World Report

This article was originally published on this site


U.S. News & World Report
Rite Aid Is Running Out of Options
U.S. News & World Report
However, with the stock now trading at around $1.50 per share, Agnese says additional downside may be limited. He says Rite Aid should also potentially benefit from drug reimbursement rate stabilization and a reduction in generic drug purchasing costs

and more »